News Category
A large study reveals that colorectal cancer patients who develop brain metastases have shorter survival, with timing significantly impacting prognosi...
Onco-Innovations reports significant progress in developing ONC010, a PNKP inhibitor for cancer therapy, including high-purity API production and plan...
OS Therapies is set to engage with investors at the Moody Capital conference while approaching critical regulatory decisions and data readouts for its...
A preclinical study suggests that administering immunotherapy before tumor removal surgery could improve treatment outcomes for glioblastoma patients,...
The FDA's failure to aggressively combat the illegal online sale of retatrutide, an unapproved investigational drug, has led to a dangerous black mark...
New research from Mass General Brigham shows that unintended radiation exposure to the thymus during lung cancer treatment is associated with worse cl...
Tonix Pharmaceuticals will showcase its CNS and immunology pipeline at the Cantor 2026 Global Healthcare Conference, highlighting recent approvals and...
NurExone Biologic will showcase its exosome-based therapeutic platform and U.S. initiatives at a New York conference, highlighting progress toward cli...
CNS Pharmaceuticals' Chief Business Officer discussed the company's focused pipeline strategy and deal-making criteria, signaling a disciplined approa...
Salman Fazal, MD, a hematologist and transplant specialist at UPMC Hillman Cancer Center in Harrisburg, has been named a 2026 Castle Connolly Top Doct...
Quantum BioPharma's Lucid-MS candidate for progressive multiple sclerosis earns a 'Buy' rating and $8 price target from Rodman & Renshaw, highlighting...
NanoViricides is progressing its measles treatment NV-387 to Phase II trials, leveraging FDA designations, as measles cases surge globally.
TransCode Therapeutics announced preclinical results showing its lead candidate TTX-MC138 improves survival in a breast cancer bone metastasis model, ...
Oragenics reports progress in its Phase IIa trial for a concussion treatment and responds to NYSE American listing deficiency, highlighting regulatory...
A nurse's personal battle with metastatic triple-negative breast cancer underscores the importance of understanding new treatments like antibody-drug ...
In a Novartis-sponsored discussion, a prostate cancer patient and a Prostate Cancer Foundation expert highlight the importance of PSMA testing for gui...
An updated expert consensus on nocturnal enuresis in children provides 18 recommendations to improve diagnosis, treatment, and referral, emphasizing i...
A new randomized controlled trial tests whether a school-based plyometric and high-intensity interval training program can improve muscle-to-fat ratio...
A University of Houston study contradicts the long-held 'shunting theory' that ECT is safe, showing 82.5% of current flows through the brain, promptin...
Creative Biolabs updates its in vivo CAR-T development portfolio with viral and non-viral approaches, offering researchers new options to overcome ex ...
Heidelberg Pharma and Huadong Medicine have received NMPA approval for a Phase Ib/II trial of HDP-101 in combination therapies for relapsed/refractory...
A new peer-reviewed study published in Critical Care Medicine shows that VolitionRx's Nu.Q NETs H3.1 biomarker independently predicts 28-day mortality...
Retatrutide, an unapproved investigational drug, is being illegally sold online, leading to a 265% increase in poison control reports and hospitalizat...
Lakewood-Amedex Biotherapeutics, a clinical-stage biotech developing the novel Bisphosphocin class of antimicrobials, becomes a B2i Digital Featured C...
Citius Pharmaceuticals is transitioning to a commercial-stage biopharma with FDA-approved LYMPHIR generating revenue, while advancing late-stage candi...
Annovis Bio announced a corporate update webinar for September 2, discussing its Phase 3 Alzheimer's trial, open-label studies, and regulatory milesto...
A new study suggests a personalized mRNA vaccine can prevent melanoma recurrence for years, offering hope for cancer treatment.
Creative Biolabs announces a webinar featuring Dr. Greg M. Delgoffe to discuss modeling T cell dysfunction in the tumor microenvironment, highlighting...
A new T cell therapy could transform treatment for recurrent glioblastoma, a disease with few effective options, offering new hope for patients.
VERAXA Biotech and Secarna's early in vitro results show their AOC candidate is more potent than unconjugated oligonucleotides, supporting the approac...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate program into the next development stage after completing the initial OmniAb co...
Scinai Immunotherapeutics reported increased revenue and a net profit for the first half of 2026, while advancing an expanded clinical manufacturing p...
A new composite scoring system, the Seven Up score, may prevent overtreatment of early rejection in liver transplant recipients, as research shows mos...
A new review suggests that delivering healthy mitochondria to donor organs during machine perfusion could repair cellular damage, potentially increasi...
VERAXA Biotech received favorable Scientific Advice from Germany's Paul-Ehrlich-Institute for its lead BiTAC-TCE cancer therapy, potentially reducing ...
Onco-Innovations has entered a non-binding LOI with Ifowonco Informatics to potentially acquire an exclusive option on a small-molecule LAG-3 inhibito...
Creative Biolabs has expanded its complement assay services to help researchers evaluate complement-targeting therapeutics, addressing the growing nee...
Quantum BioPharma is advancing a novel MS treatment focusing on myelin protection, potentially addressing disease progression that current therapies m...
Silo Pharma's lead asset SPC-15, an intranasal treatment for PTSD, has received a Notice of Allowance from the Canadian Intellectual Property Office, ...
Quantum BioPharma's FDA-cleared phase 2 trial of Lucid-MS highlights a shift in MS treatment toward protecting the nervous system, addressing an unmet...
Regentis Biomaterials received a Japanese Notice of Allowance for its solvent-free manufacturing process and liquid formulation for GelrinC, strengthe...
VERAXA Biotech's collaboration with Ardigen aims to use AI to identify optimal dual-target combinations for cancer therapies, potentially reducing dev...
VERAXA Biotech's collaboration with AI-focused Ardigen aims to use artificial intelligence to identify optimal dual-target combinations for cancer the...
The American Heart Association is accepting applications for its 2026 Health Tech Competition, aiming to bridge the gap between promising health techn...
Researchers have identified a protein on glioblastoma cells that could be targeted to make the cancer more vulnerable to existing treatments, potentia...
NanoViricides expects to begin a Phase II clinical trial of its oral antiviral NV-387 for Ebola in the DRC, potentially offering a more accessible tre...
Helus Pharma announced the appointment of Regina Donohue as Chief People Officer and Dr. Suresh Durgam to its Scientific Advisory Board, signaling a s...
The 20th Annual Sickle Cell Disease Educational Summit, hosted by Cayenne Wellness Center, will celebrate two decades of progress in treatment and adv...
